GFM
INDV icon

GF Fund Management’s Indivior Pharmaceuticals INDV Stock Holding History

GF Fund Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Sell
2,648
-156
-6% -$5.66K ﹤0.01% 326
2026
Q1 		$85.5K Buy
2,804
+351
+14% +$11.6K ﹤0.01% 355
2025
Q4 		$88K Sell
2,453
-231
-9% -$7.05K ﹤0.01% 356
2025
Q3 		$64.7K Sell
2,684
-806
-23% -$16.9K ﹤0.01% 370
2025
Q2 		$51.4K Hold
3,490
– – ﹤0.01% 412
2025
Q1 		$33.3K Buy
3,490
+628
+22% +$6.6K ﹤0.01% 451
2024
Q4 		$35.6K Buy
+2,862
New +$29.4K ﹤0.01% 421

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GF Fund Management's INDV Position: Q2 2026 in Review

GF Fund Management reduced its Indivior Pharmaceuticals (INDV) stake by 5.6% in Q2 2026, selling an estimated $5.66K and leaving 2,648 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #326.

GF Fund Management first reported a position in INDV in Q4 2024 and has held it in 7 quarters since. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • GF Fund Management held 2,648 shares of Indivior Pharmaceuticals worth $109K as of Q2 2026.
  • GF Fund Management sold 156 Indivior Pharmaceuticals shares in Q2 2026, an estimated $5.66K.
  • Indivior Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #326 holding.
  • GF Fund Management first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.